Software - Application
Compare Stocks
5 / 10Stock Comparison
IDAI vs ACXP vs AIOT vs CEVA vs MSFT
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Communication Equipment
Semiconductors
Software - Infrastructure
IDAI vs ACXP vs AIOT vs CEVA vs MSFT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Biotechnology | Communication Equipment | Semiconductors | Software - Infrastructure |
| Market Cap | $3M | $5M | $463M | $810M | $3.13T |
| Revenue (TTM) | $4M | $0.00 | $436M | $108M | $318.27B |
| Net Income (TTM) | $-12M | $-7.97B | $-32M | $-11M | $125.22B |
| Gross Margin | 60.0% | — | 55.2% | 87.2% | 68.3% |
| Operating Margin | -183.3% | — | 1.7% | -10.1% | 46.8% |
| Forward P/E | — | — | — | 67.3x | 25.3x |
| Total Debt | $4M | $0.00 | $287M | $6M | $112.18B |
| Cash & Equiv. | $3M | $7.56B | $49M | $18M | $30.24B |
IDAI vs ACXP vs AIOT vs CEVA vs MSFT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 24 | May 26 | Return |
|---|---|---|---|
| T Stamp Inc. (IDAI) | 100 | 35.7 | -64.3% |
| Acurx Pharmaceutica… (ACXP) | 100 | 4.7 | -95.3% |
| PowerFleet, Inc. (AIOT) | 100 | 74.4 | -25.6% |
| CEVA, Inc. (CEVA) | 100 | 174.8 | +74.8% |
| Microsoft Corporati… (MSFT) | 100 | 94.2 | -5.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IDAI vs ACXP vs AIOT vs CEVA vs MSFT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IDAI lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, ACXP doesn't own a clear edge in any measured category.
AIOT is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 66.3%, EPS growth 60.6%, 3Y rev CAGR 42.2%
- 66.3% revenue growth vs IDAI's -32.4%
- 22.2% yield, 1-year raise streak, vs MSFT's 0.8%, (3 stocks pay no dividend)
CEVA ranks third and is worth considering specifically for momentum.
- +59.5% vs ACXP's -70.1%
MSFT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 19 yrs, beta 0.89, yield 0.8%
- 7.9% 10Y total return vs CEVA's 27.2%
- Lower volatility, beta 0.89, Low D/E 32.7%, current ratio 1.35x
- Beta 0.89, yield 0.8%, current ratio 1.35x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 66.3% revenue growth vs IDAI's -32.4% | |
| Value | Lower P/E (25.3x vs 67.3x) | |
| Quality / Margins | 39.3% margin vs IDAI's -316.4% | |
| Stability / Safety | Beta 0.89 vs CEVA's 2.76 | |
| Dividends | 22.2% yield, 1-year raise streak, vs MSFT's 0.8%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +59.5% vs ACXP's -70.1% | |
| Efficiency (ROA) | 19.2% ROA vs ACXP's -413.5% |
IDAI vs ACXP vs AIOT vs CEVA vs MSFT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IDAI vs ACXP vs AIOT vs CEVA vs MSFT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSFT leads in 4 of 6 categories
IDAI leads 0 • ACXP leads 0 • AIOT leads 0 • CEVA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSFT leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MSFT and ACXP operate at a comparable scale, with $318.3B and $0 in trailing revenue. MSFT is the more profitable business, keeping 39.3% of every revenue dollar as net income compared to IDAI's -3.2%. On growth, IDAI holds the edge at +70.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4M | $0 | $436M | $108M | $318.3B |
| EBITDAEarnings before interest/tax | -$6M | $35,910 | $69M | -$7M | $192.6B |
| Net IncomeAfter-tax profit | -$12M | -$8.0B | -$32M | -$11M | $125.2B |
| Free Cash FlowCash after capex | -$8M | $4.6B | $3M | -$6M | $72.9B |
| Gross MarginGross profit ÷ Revenue | +60.0% | — | +55.2% | +87.2% | +68.3% |
| Operating MarginEBIT ÷ Revenue | -183.3% | — | +1.7% | -10.1% | +46.8% |
| Net MarginNet income ÷ Revenue | -3.2% | — | -7.4% | -10.5% | +39.3% |
| FCF MarginFCF ÷ Revenue | -2.2% | — | +0.6% | -6.0% | +22.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +70.7% | — | +47.4% | +4.3% | +18.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +32.1% | +98.2% | -25.5% | -2.0% | +23.4% |
Valuation Metrics
MSFT leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, MSFT's 19.7x EV/EBITDA is more attractive than AIOT's 44.2x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3M | $5M | $463M | $810M | $3.13T |
| Enterprise ValueMkt cap + debt − cash | $4M | -$7.6B | $701M | $797M | $3.21T |
| Trailing P/EPrice ÷ TTM EPS | -0.22x | -0.40x | -7.91x | -91.14x | 30.86x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 67.35x | 25.34x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.64x |
| EV / EBITDAEnterprise value multiple | — | — | 44.16x | — | 19.72x |
| Price / SalesMarket cap ÷ Revenue | 0.89x | — | 1.28x | 7.57x | 11.10x |
| Price / BookPrice ÷ Book value/share | 0.86x | 0.00x | 0.91x | 2.99x | 9.15x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 1569.47x | 43.66x |
Profitability & Efficiency
MSFT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MSFT delivers a 33.1% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $-6 for ACXP. CEVA carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to IDAI's 1.30x. On the Piotroski fundamental quality scale (0–9), CEVA scores 6/9 vs IDAI's 1/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -189.5% | -6.0% | -6.6% | -4.2% | +33.1% |
| ROA (TTM)Return on assets | -105.4% | -4.1% | -3.4% | -3.7% | +19.2% |
| ROICReturn on invested capital | -2.2% | — | -4.3% | -2.3% | +24.9% |
| ROCEReturn on capital employed | -194.9% | — | -5.1% | -2.7% | +29.7% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 3 | 3 | 6 | 6 |
| Debt / EquityFinancial leverage | 1.30x | — | 0.64x | 0.02x | 0.33x |
| Net DebtTotal debt minus cash | $1M | -$7.6B | $238M | -$13M | $81.9B |
| Cash & Equiv.Liquid assets | $3M | $7.6B | $49M | $18M | $30.2B |
| Total DebtShort + long-term debt | $4M | $0 | $287M | $6M | $112.2B |
| Interest CoverageEBIT ÷ Interest expense | -22.08x | — | 0.47x | — | 55.65x |
Total Returns (Dividends Reinvested)
MSFT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSFT five years ago would be worth $17,246 today (with dividends reinvested), compared to $95 for IDAI. Over the past 12 months, CEVA leads with a +59.5% total return vs ACXP's -70.1%. The 3-year compound annual growth rate (CAGR) favors MSFT at 11.7% vs ACXP's -67.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -38.4% | -23.2% | -35.2% | +50.4% | -10.8% |
| 1-Year ReturnPast 12 months | +20.9% | -70.1% | -32.7% | +59.5% | -2.1% |
| 3-Year ReturnCumulative with dividends | -87.5% | -96.5% | -28.7% | +31.6% | +39.5% |
| 5-Year ReturnCumulative with dividends | -99.1% | -98.7% | -28.7% | -35.4% | +72.5% |
| 10-Year ReturnCumulative with dividends | +102.4% | -98.7% | -28.7% | +27.2% | +787.7% |
| CAGR (3Y)Annualised 3-year return | -50.0% | -67.4% | -10.7% | +9.6% | +11.7% |
Risk & Volatility
Evenly matched — CEVA and MSFT each lead in 1 of 2 comparable metrics.
Risk & Volatility
MSFT is the less volatile stock with a 0.89 beta — it tends to amplify market swings less than CEVA's 2.76 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CEVA currently trades 96.7% from its 52-week high vs ACXP's 10.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.99x | 2.42x | 2.70x | 2.76x | 0.89x |
| 52-Week HighHighest price in past year | $5.28 | $21.00 | $6.07 | $34.87 | $555.45 |
| 52-Week LowLowest price in past year | $1.80 | $1.33 | $2.77 | $17.02 | $356.28 |
| % of 52W HighCurrent price vs 52-week peak | +47.2% | +10.1% | +56.0% | +96.7% | +75.8% |
| RSI (14)Momentum oscillator 0–100 | 49.1 | 40.9 | 52.2 | 78.9 | 54.0 |
| Avg Volume (50D)Average daily shares traded | 43K | 3.6M | 1.6M | 498K | 32.5M |
Analyst Outlook
Evenly matched — AIOT and MSFT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AIOT as "Buy", CEVA as "Buy", MSFT as "Buy". Consensus price targets imply 135.3% upside for AIOT (target: $8) vs -13.0% for CEVA (target: $29). For income investors, AIOT offers the higher dividend yield at 22.15% vs MSFT's 0.77%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $8.00 | $29.33 | $551.75 |
| # AnalystsCovering analysts | — | — | 5 | 23 | 81 |
| Dividend YieldAnnual dividend ÷ price | — | — | +22.2% | — | +0.8% |
| Dividend StreakConsecutive years of raises | — | — | 1 | — | 19 |
| Dividend / ShareAnnual DPS | — | — | $0.75 | — | $3.23 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +100.0% | +0.6% | +1.0% | +0.6% |
MSFT leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.
IDAI vs ACXP vs AIOT vs CEVA vs MSFT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IDAI or ACXP or AIOT or CEVA or MSFT a better buy right now?
For growth investors, Microsoft Corporation (MSFT) is the stronger pick with 14.
9% revenue growth year-over-year, versus -32. 4% for T Stamp Inc. (IDAI). Microsoft Corporation (MSFT) offers the better valuation at 30. 9x trailing P/E (25. 3x forward), making it the more compelling value choice. Analysts rate PowerFleet, Inc. (AIOT) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IDAI or ACXP or AIOT or CEVA or MSFT?
On forward P/E, Microsoft Corporation is actually cheaper at 25.
3x.
03Which is the better long-term investment — IDAI or ACXP or AIOT or CEVA or MSFT?
Over the past 5 years, Microsoft Corporation (MSFT) delivered a total return of +72.
5%, compared to -99. 1% for T Stamp Inc. (IDAI). Over 10 years, the gap is even starker: MSFT returned +787. 7% versus ACXP's -98. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IDAI or ACXP or AIOT or CEVA or MSFT?
By beta (market sensitivity over 5 years), Microsoft Corporation (MSFT) is the lower-risk stock at 0.
89β versus CEVA, Inc. 's 2. 76β — meaning CEVA is approximately 212% more volatile than MSFT relative to the S&P 500. On balance sheet safety, CEVA, Inc. (CEVA) carries a lower debt/equity ratio of 2% versus 130% for T Stamp Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IDAI or ACXP or AIOT or CEVA or MSFT?
By revenue growth (latest reported year), Microsoft Corporation (MSFT) is pulling ahead at 14.
9% versus -32. 4% for T Stamp Inc. (IDAI). On earnings-per-share growth, the picture is similar: Acurx Pharmaceuticals, Inc. grew EPS 69. 8% year-over-year, compared to 15. 6% for Microsoft Corporation. Over a 3-year CAGR, AIOT leads at 42. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IDAI or ACXP or AIOT or CEVA or MSFT?
Microsoft Corporation (MSFT) is the more profitable company, earning 36.
1% net margin versus -344. 1% for T Stamp Inc. — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSFT leads at 45. 6% versus -303. 9% for IDAI. At the gross margin level — before operating expenses — CEVA leads at 88. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IDAI or ACXP or AIOT or CEVA or MSFT more undervalued right now?
On forward earnings alone, Microsoft Corporation (MSFT) trades at 25.
3x forward P/E versus 67. 3x for CEVA, Inc. — 42. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AIOT: 135. 3% to $8. 00.
08Which pays a better dividend — IDAI or ACXP or AIOT or CEVA or MSFT?
In this comparison, AIOT (22.
2% yield), MSFT (0. 8% yield) pay a dividend. IDAI, ACXP, CEVA do not pay a meaningful dividend and should not be held primarily for income.
09Is IDAI or ACXP or AIOT or CEVA or MSFT better for a retirement portfolio?
For long-horizon retirement investors, Microsoft Corporation (MSFT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
89), 0. 8% yield, +787. 7% 10Y return). Acurx Pharmaceuticals, Inc. (ACXP) carries a higher beta of 2. 42 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSFT: +787. 7%, ACXP: -98. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IDAI and ACXP and AIOT and CEVA and MSFT?
These companies operate in different sectors (IDAI (Technology) and ACXP (Healthcare) and AIOT (Technology) and CEVA (Technology) and MSFT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IDAI is a small-cap quality compounder stock; ACXP is a small-cap quality compounder stock; AIOT is a small-cap income-oriented stock; CEVA is a small-cap quality compounder stock; MSFT is a mega-cap quality compounder stock. AIOT, MSFT pay a dividend while IDAI, ACXP, CEVA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.